Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.
Research output: Contribution to journal › Article
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Publication status||Published - 2006|
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Division of Clinical Chemistry and Pharmacology (013250300), Pediatrics/Urology/Gynecology/Endocrinology (013240400), Clinical Chemistry, Malmö (013016000), Division of Urological Cancers (013243420)